Material and Methods: 25 Patients were included, with regional nodes level I-IV. Twelve were left-sided with breathhold treatments. All were planned with both original 3DCRT and a new hybrid 3DCRT-IMRT techniques. Delineations were made according to ESTRO guidelines. Comparison was based on DVH parameters for OARs, namely lung, heart, oesophagus, contra-breast (eg V20, Dmean) and the PTV (V95%, D2%, D98%, conformity). Analysis was performed using SPSS. Further analysis focussed on the efficacy for breathhold treatments and efficiency in planning and delivery.
Purpose or Objective: Volumetric modulated arc therapy (VMAT) techniques for cranio-spinal irradiation (CSI) allows radiation delivery without any field junction. Junctions are replaced by sectors in which arcs of two consecutive isocenters overlap. The dose contribution from each arc in this sector is automatically accounted for by the treatment plan optimization process. Inaccurate patient positioning during treatment in this area of overlap between arcs belonging to different isocenters, causes regions of over-or underdosages. The purpose of this analysis is to find an optimal length of overlap between the overlapping arcs,to minimize the dose deviations that can be attributed to patient setup inaccuracies.
Material and Methods: Five (n = 5) patients undergoing CSI were planned using the Monaco 5.1 (Elekta Ltd,Crawly, UK) treatment planning system. Each plan consisted of 2 isocenters, with an overlap sector at the mid-cervical level. For the head a full clockwise-counterclockwise (cw-ccw) arc was used, while for the spine two cw-ccw partial arcs (180-260 ° and 100-181 °) . In order to assess the optimal overlap length, plans were generated for overlap sectors of 4, 6, 8 and 10 cm. Afterwards, plans were recalculated without re-optimization for a superior isocenter shift of +0.5 cm in cranio-caudal direction and a -0.5 cm in the left-right direction ,mimicking a potential patient setup error. Dose distributions of the generated plans with isocenter shift were compared to the original plans based on V90%, V95% ,V110% of the Planning Target Volume (PTV) and Conformity Index (CI).
Results:
The introduction of a shift in the superior isocenter causes a 3% decrease in the V90% of PTV independently of the overlap length (Table1).
A decrease in PTV coverage (V95%) is also observed and the effect is larger for the 10 cm overlap length. The volume receiving ≥110% of the prescribed dose increases when the length of the overlap becomes larger than 4 cm. The relative difference of the CI between the shifted and original plan is the smallest for the 6 cm overlap length. The smallest relative dosimetric deviations from the original non shifted plan are obtained for 6 cm overlap length.
Conclusion:
To reduce the impact of setup errors during CSI by VMAT, the optimal length of the overlap sector using the Monaco 5.1 treatment planning system, should be around 6 cm. allows MRI based targeting, structure autosegmentation and direct planning for numerous anatomical districts. Our department is implementing this technology and, up to date, we are testing QA planning procedures compared to our clinical standards in order to define which districts could take advantage from the use of the MRI-60Co technology. Aim of this investigation was to assess the impact of the implementation of the ViewRay magnetic resonance imaging (MRI)-guided 60Co radiation therapy system through an in silico planning analysis for cervical cancer treatments.
PO-1008 In silico implementation of MRI-60Co RT. A dosimetrical comparison in cervical cancer (SIMBAD

Material and Methods:
Patients affected by cervical cancer (cT3; cN0, cN+) were manually segmented on Eclipse TPS v11. RapidArc (6-15 MV arcs) and 5 beams (6-15 MV) sliding window IMRT treatment plans were calculated according to our usual QA protocols by skilled planners. The PTV1 (CTV1+7/10 mm margin) was represented by the tumor, the PTV2 (CTV2+7 mm margin) by drainage pelvic nodes. The OaRs considered for this analysis were the body, the bowel bag and the bladder. The total prescribed dose for PTV2 was 39.6/1.8 Gy and 50.6/2.3 Gy for PTV1 through simultaneous integrated boost. The PTV V95 and OaRs QUANTEC dose constraints on the DVHs and Wu's homogeneity indexes (HI) were then analyzed to ensure the dosimetrical reliability of the plans. The structure sets were then uploaded on the MRIdian workstation and a 60Co plan was calculated by beginner planners after a specific training session. The DHVs and HI were then compared to the RapidArc and IMRT gold standard in order to evaluate MRIdian's performances.
Results:
We calculated ten sets of three plans (MRI-60Co, RapidArc and 5 beams static IMRT) for ten consecutive patients. The MRI-60Co system showed a better HI when compared to the other techniques for PTV1, while this advantage could not be appreciated for PTV2, even if a better PTV2 V100 (39.6 Gy) was observed. Comparable mean doses for the bladder were registered, while a higher bowel V45 was observed (even if still in the constraints limits). Low dose body V5 was higher for the MRI-60Co system. The results are summarized in table 1.
Conclusion:
We registered an higher PTV dose coverage between MRIdian's and the RapidArc and IMRT plans for cervical cancer, with a HI advantage for the PTV1. Differences were described for OaRs, especially for low dose areas (V5 Body). The MRIdian's planning platform showed to be user friendly and allowed to reach dosimetrical goals comparable to RapidArc and IMRT gold standards. The evaluation of a possible reduction in PTV margins and a proper target coverage by MRI based gating will be analyzed when the system will become operative.
PO-1009
VMAT planning approach to avoid superficial underdosage for accelerated partial breast irradiation F. Zucconi Purpose or Objective: Accelerated Partial Breast Irradiation (APBI) is a RT approach that treats only the lumpectomy bed plus a margin, rather than the whole breast. The dose fluence outside the breast contour to account for breathing and residual motions can be manually increased with RapidArc/VMAT. At this aim, a 10 mm virtual expansion of the breast with soft-tissue equivalent HU is usually applied to the CT series (CT_E) and the optimization is performed on the APBI target expanded along the anterior/lateral directions. However, the dose recalculated on the original CT series (CT_O) could underdose the superficial target volume. In this study, a simple technical strategy to increase the target superficial dose is presented.
Material and Methods: Ten patients treated by APBI were randomly selected from the internal database (41 patients since 06/14). PTV_O was defined on CT_O as the tumor bed + 1-2cm, cropping it of 5 mm to the body. Dose prescription was 30 Gy in 5 fractions. Plans were normalized to PTV_O mean dose. PTV_E was defined on CT_E, expanding PTV_O of 10 mm in anterior/lateral directions. PTV_E was subdivided in three parts: PTV_EI (PTV_E cropped of 7 mm from the CT_O body -internal), PTV_ES (PTV_E cropped 5-7 mmsuperficial), PTV_EE (PTV_E minus PTV_EI and PTV_ESexternal). Two plans were optimized on the CT_E: (i) prescribing the same dose to the three PTVs, (ii) PTV_EI = 30 Gy, PTV_ES = 32 Gy, PTV_EE = 33 Gy. Final dose calculations for the two optimizations were performed on the CT_O. Plan objectives were: D98% (dose received by 98% of the target volume) > 95% and D2% < 107% for PTV, minimizing the homogeneity index (HI= D2%-D98%); V15Gy (volume of the organ receiving 15Gy) < 50% for breast minus PTV; V10Gy < 20% for ipsilateral lung; V5Gy < 10% for controlateral lung; V3-5Gy < 10% for heart, Dmax < 1-2 Gy for controlateral breast. Plans were compared in terms of dosimetric plan objectives findings.
